Literature DB >> 26490774

[Semen allergy].

J-P Allam1, G Haidl2, N Novak2.   

Abstract

A semen allergy is a type I reaction. Reliable figures about incidence/prevalence are not available. Symptoms can be characterized as local and systemic. After exposure to ejaculate, the patient may experience itching and swelling at points of contact, while systemically it may also lead to generalized urticaria with angioedema or higher grade anaphylaxis. As triggering allergens, substances in seminal plasma (SP) have been identified, which can be SP typical or SP atypical. Reactions against spermatozoa have not yet been clearly proven. With regard to SP-typical allergens, prostate-specific antigen (PSA) has been identified, while for SP-atypical allergens, medications or food allergens have been reported, which apparently accumulate in the SP and can then trigger symptoms in women with existing sensitization. The main criteria for the diagnosis of sperm allergy is freedom from symptoms when condoms are used during intercourse. In addition, skin prick tests and determination of allergen-specific IgE are used. In patients with a desire for children, washed, SP-free spermatozoa can be used for insemination. In addition, desensitization may be considered.

Entities:  

Keywords:  Allergens; Anaphylaxis; Desensitization, immunologic; Ejaculation; Insemination

Mesh:

Year:  2015        PMID: 26490774     DOI: 10.1007/s00105-015-3710-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  30 in total

1.  Allergy to human seminal fluid.

Authors:  E J Mikkelsen; L L Henderson; K M Leiferman; G J Gleich
Journal:  Ann Allergy       Date:  1975-04

2.  Prostate-specific antigen as allergen in human seminal plasma allergy.

Authors:  Stephan Weidinger; Artur Mayerhofer; Romi Raemsch; Johannes Ring; Frank-Michael Köhn
Journal:  J Allergy Clin Immunol       Date:  2005-12-02       Impact factor: 10.793

3.  Intravaginal desensitization and successful pregnancy in a woman with seminal fluid allergy.

Authors:  C De Cuyper; Y Bogaerts; F Vandekerckhove; J Gunst
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

4.  Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).

Authors:  Marcel D Waldinger; Marcus M H M Meinardi; Dave H Schweitzer
Journal:  J Sex Med       Date:  2011-01-17       Impact factor: 3.802

5.  Allergy to human seminal plasma.

Authors:  B B Levine; R P Siraganian; I Schenkein
Journal:  N Engl J Med       Date:  1973-04-26       Impact factor: 91.245

6.  Local intravaginal desensitization to seminal fluid.

Authors:  S M Matloff
Journal:  J Allergy Clin Immunol       Date:  1993-06       Impact factor: 10.793

Review 7.  Seminal plasma hypersensitivity reactions: an updated review.

Authors:  J Wesley Sublett; Jonathan A Bernstein
Journal:  Mt Sinai J Med       Date:  2011 Sep-Oct

8.  Localized and systemic hypersensitivity reactions to human seminal fluid.

Authors:  I L Bernstein; B E Englander; J S Gallagher; P Nathan; Z H Marcus
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

9.  Woman allergic to husband's sweat and semen.

Authors:  S Freeman
Journal:  Contact Dermatitis       Date:  1986-02       Impact factor: 6.600

10.  Testing for hypersensitivity to seminal fluid-free spermatozoa.

Authors:  Michael Carroll; Gregory Horne; Richard Antrobus; Cheryl Fitzgerald; Daniel Brison; Matthew Helbert
Journal:  Hum Fertil (Camb)       Date:  2013-06-10       Impact factor: 2.767

View more
  2 in total

Review 1.  Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation.

Authors:  Seema Patel
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-28       Impact factor: 4.806

Review 2.  [Mucosal diseases from an allergological perspective].

Authors:  I Schwarz; D Bokanovic; W Aberer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.